m schmitz schumann (15 resultados)

Hardcover. Condición: Very Good.

Hardcover. Condición: Fine.

Hardcover. Condición: Near Fine. No Jacket. 0817618066. A very good ex lib. hardcover. Lending record shows this book has never been borrowed. 260 pages, index, illustrated with charts, tables, photos and diagrams. Papers are arranged under the headings: Platelets: Activation and Production; Platelet Activating Factor; Platelet Activation in Asthma; Aspirin induced Asthma; Modulation of bronchial hyperreactivity. Contents clean, tight and bright. Book.

Hardcover. Condición: Near Fine. No Jacket. 0817622896. An ex pharmaceutical company library hardcover, with minimal wear. Lending record shows this book has never been borrowed. 378 pages, index, illustrated with charts, tables and diagrams. Papers presented during a Symposium held at the 4th International Symposium, Hochgebirgsklinik Davos, September, 1988. Book.

Condición: New. In.

Condición: New. Series: Agents and Actions, Supplements. Num Pages: 260 pages, biography. BIC Classification: MJL; PD. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 461. . 2012. Softcover reprint of the original 1st ed. 1987. paperback. . . . .

Paperback. Condición: Brand New. 264 pages. 9.61x6.69x0.60 inches. In Stock.

Condición: New. Series: Agents and Actions, Supplements. Num Pages: 260 pages, biography. BIC Classification: MJL; PD. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 461. . 2012. Softcover reprint of the original 1st ed. 1987. paperback. . . . . Books ship from the US and Ireland.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Bronchial asthma is a disease with many unsolved problems and despite an increased availabili ty of anti-asthma drugs, morbidi ty and mortality from this disease are not improving. It is now recognized that asthma should be considered as a chronic inflammatory disease of the lung resulting in bronchial hyperreactivity and subsequent symptoms. The mechanisms underlying airways inflammation and bronchial hyperreactivity have now become a focal point of research in the quest for knowledge about how the management of this disease can be improved. Platelet activating factor (PAF-acether AGEPC) is a naturally occurring ether-linked phospholipid discovered in 1972 associated with IgE mediated allergic responses which has potent effects on platelet activation. PAF is now recognized as a molecule having a diverse range of biological effects relevant to allergic inflammation and asthma including the abili ty to induce long lasting airway inflammation and associated increases in bronchial reactivity. Certain activities of PAF are known to be secondary to platelets activation raising the possibility that this blood element plays a role in the pathogenesis of asthma.

Paperback. Condición: Like New. Like New. book.

hardcover. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condición: new. Questo è un articolo print on demand.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Bronchial asthma is a disease with many unsolved problems and despite an increased availabili ty of anti-asthma drugs, morbidi ty and mortality from this disease are not improving. It is now recognized that asthma should be considered as a chronic inflammatory disease of the lung resulting in bronchial hyperreactivity and subsequent symptoms. The mechanisms underlying airways inflammation and bronchial hyperreactivity have now become a focal point of research in the quest for knowledge about how the management of this disease can be improved. Platelet activating factor (PAF-acether AGEPC) is a naturally occurring ether-linked phospholipid discovered in 1972 associated with IgE mediated allergic responses which has potent effects on platelet activation. PAF is now recognized as a molecule having a diverse range of biological effects relevant to allergic inflammation and asthma including the abili ty to induce long lasting airway inflammation and associated increases in bronchial reactivity. Certain activities of PAF are known to be secondary to platelets activation raising the possibility that this blood element plays a role in the pathogenesis of asthma. 264 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Bronchial asthma is a disease with many unsolved problems and despite an increased availabili ty of anti-asthma drugs, morbidi ty and mortality from this disease are not improving. It is now recognized that asthma should be considered as a chronic inflammat.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Bronchial asthma is a disease with many unsolved problems and despite an increased availabili ty of anti-asthma drugs, morbidi ty and mortality from this disease are not improving. It is now recognized that asthma should be considered as a chronic inflammatory disease of the lung resulting in bronchial hyperreactivity and subsequent symptoms. The mechanisms underlying airways inflammation and bronchial hyperreactivity have now become a focal point of research in the quest for knowledge about how the management of this disease can be improved. Platelet activating factor (PAF-acether AGEPC) is a naturally occurring ether-linked phospholipid discovered in 1972 associated with IgE mediated allergic responses which has potent effects on platelet activation. PAF is now recognized as a molecule having a diverse range of biological effects relevant to allergic inflammation and asthma including the abili ty to induce long lasting airway inflammation and associated increases in bronchial reactivity. Certain activities of PAF are known to be secondary to platelets activation raising the possibility that this blood element plays a role in the pathogenesis of asthma.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 264 pp. Englisch.